Catheter-associated urinary tract infections: Epidemiology and prevention;Le infezioni urinarie associate a catetere: Epidemiologia e prevenzione

Infezioni in Medicina

Volumn 16, Issue 3, 2008, Pages 130-143

  Esposito, Silvano ^a   Noviello, Silvana ^a   Leone, Sebastiano ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Silver alloy catheters; Silver coated catheters; Urinary tract infections

Indexed keywords

ALLOY; GOLD; PLATINUM; SILVER;

BLADDER CATHETERIZATION; CATHETER INFECTION; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; MATERIAL COATING; MEDICAL INSTRUMENTATION; PATHOGENESIS; REVIEW; URINARY TRACT INFECTION;

AGED; ALLOYS; BACTERIURIA; BIOFILMS; COATED MATERIALS, BIOCOMPATIBLE; ENTEROBACTERIACEAE INFECTIONS; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; HYDROGELS; INTENSIVE CARE; LONG-TERM CARE; MALE; MULTICENTER STUDIES AS TOPIC; OXIDES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SILVER COMPOUNDS; URETHRA; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

EID: 54849406420     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113 (Suppl. 1A), 5S-13S, 2002.
2. Mazzulli T. Resistance trends in urinary tract pathogens and impact on management. J. Urol. 168, 1720-1722, 2002.
3. Haley R.W., Culver D.H., White J.W., Morgan W.M., Emori T.G. The nationwide nosocomial infection rate. A new need for vital statistics. Am. J. Epidemiol. 121, 159-167, 1985.
4. Lai K.K., Fontecchio S.A. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am. J. Infect. Control. 30 (4), 221-225, 2002.
5. Patton J.P., Nash D.B., Abrutyn E. Urinary tract infection: economic considerations. Med. Clin. North Am. 75, 495-513, 1991.
6. European Association of Urology. Guidelines on: The management of urinary and male genital tract infections. Naber K.G. (Chairman), Bishop M.C., Bjerklund-Johansen T.E., Botto H., Çek M., Grabe, M. Lobel B., Palou J., Tenke P. 2006.
7. Kahlmeter G., ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J. Antimicrob. Chemother. 51 (1), 69-76, 2003.
8. Nicolle L.E. Resistant pathogens in urinary tract infections. J. Am. Geriatr. Soc. 50 (7 Suppl), S230-S235, 2002.
9. Nicolle L.E., Garibaldi R., Strausbaugh L.J. Infections and antibiotic resistance in nursing homes. Clin. Microbiol. Rev. 9, 1-17, 1996.
10. Zimmer J.G., Bentley D.W., Valenti W.M., Watson NM. Systemic antibiotic use in nursing homes. A quality assessment. J. Am. Geriatr. Soc. 34, 703-710, 1986.
11. Katz P.R., Beam T.R., Brand F., Boyer K. Antibiotic use in the nursing home. Physician practice patterns. Arch. Intern. Med. 150, 1465-1468, 1990.
12. Lee Y.L., Thrupp L.D., Friis R.H., Fine M., Maleki P., Cesario T.C. Nosocomial infection and antibiotic utilization in geriatric patients: a pilot prospective surveillance program in skilled nursing facilities. Gerontology 38, 223-232, 1992.
13. Nicolle L.E. Urinary tract infections in long-term care facilities. Infect. Control Hosp. Epidemiol. 14, 220-225, 1993.
14. Warren J.W., Tenney J.H., Hoopes J.M., Muncie H.L., Anthony W.C. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J. Infect. Dis. 146, 719-723, 1982.
15. Eberle C.M., Winsemius D., Garibaldi R.A. Risk factors and consequences of bacteriuria in non-catheterized nursing home residents. J. Gerontol. 48, M266-M271, 1993.
16. Nicolle L.E. Asymptomatic bacteriuria in the elderly. Infect Dis. Clin. North Am. 11, 647-662, 1997.
17. Nicolle L.E., Mayhew W.J., Bryan L. Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am. J. Med. 83, 27-33, 1987.
18. Bjork D.T., Pelletier L.L., Tight R.R. Urinary tract infections with antibiotic resistant organisms in catheterized nursing home patients. Infect. Control 5, 173-176, 1984.
19. Dontas A.S., Kasviki-Charvati P., Papnayiotou P.C., Marketos S.G. Bacteriuria and survival in old age. New Engl. J. Med. 304, 939-943, 1981.
20. Nordenstam G.R., Brandberg A., Oden A.S., et al. Bacteriuria and mortality in an elderly population. New Engl. J. Med. 314, 1152-1156, 1986.
21. Muder R.R., Brennen C., Wagener M.M., Goetz A.M. Bacteremia in a long term care facility: a five-year prospective study of 163 consecutive episodes. Clin. Infect. Dis. 14, 647-654, 1992.
22. Lee YL, Thrupp LD, Lee R, Nothvogel S, Farsad N, Cesario T. Infection surveillance and antibiotic utilization in a community-based skilled nursing facility. Aging (Milano). 8 (2), 113-122, 1996.
23. Toubes E., Singh K., Yin D., et al. Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference? Clin. Infect. Dis. 15, 36 (6), 724-730, 2003.
24. Elizaga M.L., Weinstein R.A., Hayden M.K. Patients in Long-Term Care Facilities: A Reservoir for Vancomycin-Resistant Enterococci. Clin. Infect. Dis. 34, 441-446, 2002.
25. Rosser C.J., Bare R.L., Meredith J.W. Urinary tract infections in the critical ill patient with a urinary catheter. Am. J. Surg. 177, 287-290, 1999.
26. Leone M., Albanese J., Garnier F., et al. Risk factors of nosocomial catheter-associated urinary tract infection in a polyvalent intensive care unit. Intensive Care Med. 29, 1077-1080, 2003.
27. Leone M., Garnier F., Avidan M., Martin C. Catheter-associated urinary tract infections in intensive care units. Microbes Infect. 6 (11), 1026-1032, 2004.
28. Wagenlehner F.M.E., Loibl E., Vogel H., Naber K.G. Incidence of nosocomial urinary tract infections on a surgical intensive care unit and implications for management. Int. J. Antimicrob. Agents 28 (Suppl. 1), S86-S90, 2006.
29. Nosocomial Infection National Surveillance service. Surveillance of hospital-acquired bactaeremia in English Hospitals. London: Public Health laboratory service, 2000.
30. th edition.
31. Maki D.G., Tambyah P.A. Engineering out the risk for infection with urinary catheters. Emerg. Infect. Dis. 7 (2), 342-347, 2001.
32. Platt R., Polk B.F., Murdock B., et al. Risk factors for nosocomial urinary tract infection. Am. J. Epidemiol. 124, 977-85, 1986.
33. Stamm W.E. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am. J. Med. 91 (Suppl 3B), 65S-71S, 1991.
34. Warren J.W., Steinberg L., Hebel J.R, et al. The prevalence of urethral catheterization in Maryland nursing homes: estimates for the United States. Arch. Intern. Med. 149, 1535-1537, 1989.
35. Warren J.W., Damron D., Tenney J.H., et al. Fever, bacteremia, and death as complications of bacteriuria in women with long term urethral catheters. J. Infect. Dis. 155, 1151-1158, 1987.
36. Rudman D., Hontanosas A., Cohen Z., et al. Clinical correlates of bacteremia in a Veterans Administration extended care facility. J. Am. Geriatr. Soc. 36, 726-732, 1988.
37. Warren J.W., Muncie H.L. Jr., Hall-Craggs M. Acute pyelonephritis associated with the bacteriuria of long-term catheterization: a prospective clinicopathological study. J. Infect. Dis. 158, 1341-1346, 1988.
38. Mobley H.L.T., Warren J.W. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J. Clin. Microbiol. 25, 2216-2217, 1987.
39. Mobley H.L.T., Hausinger R.P. Microbial ureases: significance, regulation, and molecular characterization. Microbiol. Rev. 53 (1), 85-108, 1989.
40. Warren J.W., Muncie H.L.Jr., Hebel J.R., et al. Long-term urethral catheterization increases risk of chronic pyelonephritis and renal inflammation. J. Am. Geriatr. Soc. 42, 1286-1290, 1994.
41. Tribe C.R., Silver J.R. Renal Failure in Paraplegia. London: Pitman Medical Publishing, 1969.
42. Locke J.R., Hill D.E., Walzer Y. Incidence of squamous cell carcinoma in patients with long-term catheter drainage. J. Urol. 133, 1034-1035, 1985.
43. Edwards L.E., Lock R., Powell C., Jones P. Post-catheterization urethral strictures. A clinical and experimental study. Br. J. Urol. 55, 53-56, 1983.
44. Stickler D.J., Evans A., Morris N., Hughes G. Strategies for the control of catheter encrustation. Int. J. Antimicrob. Agents 19, 499-506, 2002.
45. Sofer M., Denstedt J.D. Encrustation of biomaterials in the urinary tract. Curr. Opin. Urol. 10, 563-569, 2000.
46. Stickler D.J. Biomaterials to prevent nosocomial infections: is silver the gold standard? Curr. Opin. Infect. Dis. 13, 389-393, 2000.
47. Schierholz J.M., Konig D.P., Beuth J., Pulverer G. The myth of encrustation inhibiting materials. J. Hosp. Infect. 42, 162-163, 1999.
48. Johnson J.R., Delavari P., Azar M. Activities of a nitro-furazone- containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection. Antimicrob. Agents Chemother. 43, 2990-2995, 1999.
49. th Decennial International Conference on Nosocomial and Healthcare-Associated Infections. Atlanta, GA: 2000.
50. Darouiche R.O., Smith J.A. Jr, Hanna H., et al. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 54, 976-981, 1999.
51. Liedberg H.L. Prospective study of incidence of urinary tract infection in patients catheterized with BARD hydrogel and silver-coated catheters or Bard hydrogel-coated catheters. J. Urol. 149, 405A, 1993.
52. Lundeberg T. Prevention of catheter-associated urinary-tract infections by use of silver-impregnated catheters. Lancet 2 (8514), 1031, 1986.
53. Stickler D.J., Evans A., Morris N., Hughes G. Strategies for the control of catheter encrustation. Int. J. Antimicrob. Agents 19, 499-506, 2002.
54. Ruggieri M.R., Hanno P.M., Levin R.M. Reduction of bacterial adherence to catheter surfaces with heparin. J. Urol. 138, 423-426, 1987.
55. Hildebrandt P., Rzany A., Bolz A., Schaldach M. Immobilized heparin as an incrustation-resistant layer on urologic implants. Biomed. Tech. (Berl); 42 (Suppl), 123-124, 1997.
56. Riedl C.R., Witkowski M., Plas E., Pflueger H. Heparin coating reduces encrustation of ureteral stents: a preliminary report. Int. J. Antimicrob. Agents 19, 507-510, 2002.
57. Tenke P., Riedl C.R., Jones G.L., Williams G.J., Stickler D., Nagy E. Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy. Int. J. Antimicrob. Agents 23 (Suppl 1), S67-S74, 2004.
58. Costerton J.W. Introduction to biofilm. Int. J. Antimicrob. Agents 11, 217-221, 1999.
59. Kumoh I. Pathogenesis and management of bacterial biofilms in the urinary tract. J. Infect. Chemother. 2, 18-28, 1996.
60. Kumon H., Hashimoto H., Nishimura M., Monden K., Ono N. Catheter-associated urinary tract infections: impact of catheter materials on their management. Int. J. Antimicrob. Agents 17 (4), 311-316, 2001.
61. Liedberg H., Lundeberg T. Silver coating of urinary catheters prevents adherence and growth of Pseudomonas aeruginosa. Urol. Res. 17, 357-358, 1989.
62. Bologna R.A., Tu L.M., Polansky M., Fraimow H.D., Gordon D.A., Whitmore K.E. Hydrogel-silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology 54, 982-987, 1999.
63. Schaeffer A.J., Story K.O., Johnson S.M. Effect of silver oxide/tricholoroisocyanuric acid antimicrobial urinary drainage system on catheter-associated bacteriuria. J. Urol. 139, 69-73, 1988.
64. Akiyama H., Okamoto S. Prophylaxis of indwelling urethral catheter infection. Clinical experience with a modified Foley catheter and drainage system. J. Urol. 121, 40-42, 1979.
65. Lundeberg T. Prevention of catheter-associated urinary tract infections by use of silver-impregnated catheters. Lancet 2, 1031, 1986.
66. Johnson J.R., Roberts P.L., Olsen R.J., Moyer K.A., Stamm W.E. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J. Infect. Dis. 162, 1145-1150, 1990.
67. Takeuchi H., Hida S., Yoshida O., Ueda T. Clinical study on efficacy of a Foley catheter coated with silver-protein in prevention of urinary tract infections. Hinyokika Kiyo 39 (3), 293-298, 1993.
68. Riley D.K., Classen D.C., Stevens L.E., Burke J.P. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am. J. Med. 98, 349-356, 1995.
69. Saint S., Elmore J.G., Sullivan S.D., Emerson S.S., Koepsell T.D. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am. J. Med. 105, 236-241, 1998.
70. Liedberg H., Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br. J. Urol. 65, 379-381, 1990.
71. Liedberg H., Lundberg T., Ekman P. Refinements in the coating of urethral catheters reduce the incidence of catheter-associated bacteriuria. An experimental and clinical study. Eur. Urol. 17, 236-240, 1990.
72. Gabriel M.M., Sawant A.D., Simmons R.B., Ahearn D.G. Effects of silver on adherence of bacteria to urinary catheters: in vitro studies. Curr. Microbiol. 30, 17-22, 1995.
73. Maki D.G., Knasinski V., Halvorson K., Tambyah P.A. A novel silver-hydrogel impregnated indwelling urinary catheter reduces CAUTIs: a prospective double blind trial. Infect. Control Hosp. Epidemiol. 1992, 19, 682, 1998.
74. Ramirez R., Dobin A., Britten E., Wadman S. A silver opportunity for reducing nosocomial urinary tract infections [Abstract S28]. Infect. Control. Hosp. Epidemiol. 17, 700, 1998.
75. Verleyen P., De Ridder D., Van Poppel H., Baert L. Clinical application of the Bardex IC Foley catheter. Eur. Urol. 36, 240-246, 1999.
76. Saint S., Veenstra D.L., Sullivan S.D., Chenoweth C., Fendrick M. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch. Intern. Med. 160, 2670-2675, 2000.
77. Karchmer T.B., Giannetta E.T., Muto C.A., Strain B.A., Farr B.M. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch. Intern. Med. 160, 3294-3298, 2000.
78. Newton T., Still J.M., Law E. A comparison of the effect of early insertion of standard latex and silver-impregnated latex Foley catheters on urinary tract infections in burn patients. Infect. Control. Hosp. Epidemiol. 23 (4), 217-218, 2002.
79. Brosnahan J., Jull A., Tracy C. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. The Cochrane Library, 2007.
80. Rupp M.E., Fitzgerald T., Marion N., et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am. J. Infect. Control. 32 (8), 445-450, 2004.
81. Saint S., Chenoweth C.E. Biofilms and catheter-associated urinary tract infections. Infect. Dis. Clin. North Am. 17, 411-432, 2003.
82. Warren J.W. The catheter and urinary tract infection. Med. Clin. North Am. 75, 481-493, 1991.
83. Saint S., Lipsky B.A., Goold S.D. Indwelling urinary catheters: a one-point restraint? Ann. Intern. Med. 137, 125-127, 2002.
84. Johnson J.R., Kuskowski M.A., Wilt T.J. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann. Intern. Med. 144, 116-127, 2006.
85. Tambyah P.A., Knasinski V., Maki D.G. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect. Control Hosp. Epidemiol. 23, 27-31, 2002.
86. Tambyah P.A., Maki D.G. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch. Intern. Med. 160, 678-682, 2000.